National Bowel Cancer Screening Program
Adult

Endoscopy

Useful Management Information

  • For your patients, you are asked to:
    • encourage those who are sent a screening test and for whom the test is clinically relevant, to participate.
    • assess those with a positive result and refer them for further examination as clinically indicated, for example a colonoscopy. The National Health and Medical Research Council (NHMRC) approved Guidelines  state that participants with positive iFOBT results should have follow-up investigation unless there was a clear breach in protocol when samples were collected (e.g. menstrual blood loss close to the time of sample collection) and that colonoscopy should be performed as promptly as possible after a positive iFOBT to minimise the risk of psychological harm, although there is no evidence that prognosis is worsened within 120 days if cancer is present.
    • indicate whether a patient referred for colonoscopy is a Program participant to assist with reporting to the Program Register.
    • notify the Program Register of referral/non-referral for colonoscopy or other bowel examination for participants with a positive result. This can be done by returning the Program’s GP Assessment Form by fax, post or electronically. 
    • inform patients at average risk, or slightly above, that the NHMRC approved Guidelines recommend screening every two years, starting at age 50 years and continuing to age 74 years
    • manage patients identified as being at increased risk of bowel cancer in accordance with the NHMRC approved Guidelines .
    • manage patients (of any age) with symptoms in accordance with the NHMRC approved Guidelines, in recognition that bowel cancer can occur at any age.

Clinical Resources

Minimum Referral Criteria

Does your patient meet the minimum referral criteria?
Category 1 (appointment within 30 calendar days)
  • iFOBT positive in patients ≥ 50- 74 years old
Category 2 (appointment within 90 calendar days)
  • No category 2 criteria
Category 3 (appointment within 365 calendar days)
  • No category 3 criteria
  • Consider other treatment pathways or an alternative diagnosis
  • If the patient does not meet the criteria for referral but the referring practitioner believes the patient requires specialist review, a clinical override may be requested:
    • Please explain why (e.g. warning signs or symptoms, clinical modifiers, uncertain about diagnosis, etc.)
  • Please note that your referral may not be accepted or may be redirected to another service.

Essential Referral Information

  • NBCSP results - showing positive iFOBT result
  • NBCSP ID number
  • Patient and family history of bowel cancer
  • Medical and surgical history
  • Current medications (if relevant)

If a specific test result is unable to be obtained due to access, financial, religious, cultural or consent reasons a Clinical Override may be requested. This reason must be clearly articulated in the body of the referral.

Additional Referral Information

  • No additional referral information
Last updated 14 September 2021

Send Referrals To

Smart Referrals

Preferred Method
About Smart Referrals

Secure Web Transfer

Send to: Gold Coast Health Service District

Internal Referrals

Not available

Fax

(07) 5687 4497

Post

Booking and Referral Centre
Gold Coast University Hospital
1 Hospital Boulevard
Southport QLD 4215

Enquiries

1300 559 083

Related HealthPathways

No directly related pathways found

Service Availability

Dr Sneha John
Medical Director Endoscopy

Facilities

Gold Coast University Hospital

If you would like to send a named referral, please address it to the specialist listed above, who will allocate a suitably qualified specialist to see the patient. Alternatively, you can view a full list of our specialists.

Gold Coast Health - For Clinicians
© The State of Queensland 1995-2021 | Queensland Government
Queensland Government acknowledges the Traditional Owners of the land and pays respect to Elders past, present and future.